Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Log In

    Show
    Forgot your password?
    Log In
    Or create a new account (it's free)

    Forgot Password?

    Enter your email address and we'll send you a link to reset your password.

    Get New Password

    Sign In Required

    To save favorites, you must log in.

    Creating an account is free, easy, and takes about 60 seconds.

    Already have an MDCalc account?

    Login to link your favorites and recently used calcs

    Show
    Forgot your password?
    Log In
    Or continue to Nuance

    Attention COACH STUDY participants:

    The principal investigators of the study request that you use the official version of the modified score here.

    REACH-B Score for Hepatocellular Carcinoma (HCC)

    Estimates risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B.
    Pearls/Pitfalls

    • Derived and validated primarily in East Asian cohorts; may have limited applicability to other populations.

    • Excludes factors such as alpha fetoprotein and alcohol use, which are also known to be associated with progression to cirrhosis and HCC.

    Female
    0
    Male
    +2
    30–34
    0
    35–39
    +1
    40–44
    +2
    45–49
    +3
    50–54
    +4
    55–59
    +5
    60–65
    +6
    <15
    0
    15–44
    +1
    ≥45
    +2
    Negative
    0
    Positive
    +2
    <300 (undetectable)
    0
    300–9,999
    0
    10,000–99,999
    +3
    100,000–999,999
    +5
    ≥10⁶
    +4

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights
    Dr. Hwai-I Yang

    About the Creator

    Hwai-I Yang, PhD, is an associate research fellow at the Genomics Research Center in Taipei, Taiwan. He is also an adjunct associate professor at the Graduate Institute of Clinical Medicine at National Yang-Ming University. Dr. Yang’s primary research is focused on hepatitis epidemiology, translational epidemiology, immunoepidemiology of viral hepatitis, and immunoprevention of major cancers.

    To view Dr. Hwai-I Yang's publications, visit PubMed

    About the Creator
    Dr. Hwai-I Yang
    Also from MDCalc...
    You might be interested in...
    Guidelines
    Treatment of Hepatocellular Carcinoma

    Guideline from AASLD